Suppression of cytolytic function in murine lymphocytes exposed to 1,4-bis [(2-aminoethyl)amino]-5, 8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD): Inhibition of proliferation by cytotoxic T-lymphocyte precursors

This publication has 23 references indexed in Scilit:

• Selective immunosuppression following exposure to a novel anthraquinone, 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9, 10-anthracenedione dihydrochloride (AEAD)
  International Journal of Immunopharmacology, 1989
• Target cell specificity of immunosuppression in murine lymphocytes exposed to 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD)
  International Journal of Immunopharmacology, 1989
• Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses
  International Journal of Immunopharmacology, 1987
• Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2
  International Journal of Immunopharmacology, 1987
• Activation and growth requirements for cytotoxic and noncytotoxic T lymphocytes
  Cellular Immunology, 1984
• Induction of alloreactive immunosuppression by 1,4-bis [(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)
  International Journal of Immunopharmacology, 1984
• Molecular and biochemical pharmacology of mitoxantrone
  Cancer Treatment Reviews, 1983
• Primary generation of cytolytic T lymphocytes in the absence of DNA synthesis.
  The Journal of Experimental Medicine, 1979
• Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNA
  Journal of Pharmacy and Pharmacology, 1976
• The requirement for DNA synthesis and gene expression in the generation of cytotoxicity in vitro.
  The Journal of Experimental Medicine, 1975